Kym Denny
Vice President,
Clinical Research

As Vice President, Clinical Research, Kym Denny provides management and coordination of Constella’s clinical research services throughout Europe, Africa, Australia, and the US. Denny joined Constella with the acquisition of Origin in March 2006.

Denny has nearly 15 years of experience in clinical research, managing and monitoring clinical trials for both medicinal products and devices, including trial design and logistics, project management, clinical monitoring, data management, pharmacovigilance, and clinical consultancy services for Phase I-IV studies. With a strong site management background, Denny also has extensive international expertise in managing feasibility and site selection, patient recruitment, and the acceleration of clinical trial delivery in challenging patient populations and/or study designs.

Denny has in-depth knowledge of the healthcare and regulatory environments in the US and the EU, as well as global site management expertise in both in-patient and out-patient clinical trials settings. She has integrated US-driven protocols into the local healthcare structures and is experienced in developing and accelerating Phases I-IV clinical studies.

Prior to joining Origin in 2004, Denny was Managing Director for Harrison Clinical Research in the UK. She also spent three years on the board of directors for Profiad, Ltd, in the UK. Her experience prior to that includes Co-Founder and President of Insite Clinical Trials in the US, as well as four years as Principal Consultant for Synthesis, LLC, post tenure at InSite Clinical Trials.